Home›Stock Screener›Vaidya Sane Ayurved Laboratories›Financial Statements

Vaidya Sane Ayurved Laboratories Complete Financial Statements

4 Years of Data
2025 - 2022

In FY2023, Vaidya Sane Ayurved Laboratories (MADHAVBAUG) reported revenue ₹5,173 Cr, net profit ₹235 Cr and EPS ₹1.12, with a net profit margin of 4.5% and ROE of 373.0%. Full financial statements from FY2022 to FY2025 (4 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Vaidya Sane Ayurved Laboratori share price screener.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 4.54% 2023 data
EBITDA Margin 6.42% 2023 data
Operating Margin 5.00% 2023 data
Return on Assets 305.19% 2023 data
Return on Equity 373.02% 2023 data

Balance Sheet Ratios

Current Ratio 10.00 2023 data
Equity Ratio 81.82% 2023 data
Asset Turnover 67.18 2023 data

MADHAVBAUG Revenue, Net Profit & EBITDA — Year-on-Year Growth

MADHAVBAUG YoY (Sept 2022 vs Sept 2023) — revenue -48.5%, net profit -75.7%, EBITDA -64.0%, expenses -47.0%. Review MADHAVBAUG PE ratio trends to evaluate earnings-based valuation against sector peers.

Revenue Growth
-48.5%
Year-over-Year
Net Profit Growth
-75.7%
Year-over-Year
EBITDA Growth
-64.0%
Year-over-Year
Expense Growth
-47.0%
Year-over-Year
Assets Growth
+10.0%
Year-over-Year
Equity Growth
+12.5%
Year-over-Year
Operating Cash Flow Growth
+1200.0%
Year-over-Year
Investing Cash Flow Growth
+23.1%
Year-over-Year
Financing Cash Flow Growth
-106.7%
Year-over-Year

MADHAVBAUG Income Statement — Revenue, EBITDA & Net Profit

Vaidya Sane Ayurved Laboratories revenue ₹5,173 Cr, EBITDA ₹332 Cr, net profit ₹235 Cr, EPS ₹1.12 (2023) — net profit margin 4.5%. Explore MADHAVBAUG true value to estimate fundamental worth using multiple valuation models.

Periods ₹ Crores
Particulars Sept 2023 Jun 2023 Sept 2022
Revenue 5,173 4,641 10,053
Expenses 4,842 4,142 9,131
EBITDA 332 500 922
Operating Profit Margin % 5.00% 9.00% 8.00%
Depreciation 159 116 260
Interest 16 11 19
Profit Before Tax 157 373 643
Tax -78 126 -323
Net Profit 235 247 967
Earnings Per Share (₹) 1.12 2.60 4.60

MADHAVBAUG Balance Sheet — Assets, Liabilities & Shareholders' Equity

MADHAVBAUG total assets ₹77 Cr, total equity ₹63 Cr, total liabilities ₹ Cr (2025) — ROE 373.0%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023
ASSETS
Total Assets 77 70 55
Current Assets 30 31 28
Fixed Assets 34 28 21
Capital Work in Progress 1 3 2
Investments 15 16 14
Other Assets 27 23 19
LIABILITIES
Total Liabilities
Current Liabilities 3 3 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 63 56 41
Share Capital 11 11 11
Reserves & Surplus 52 32 30

MADHAVBAUG Cash Flow Statement — Operating, Investing & Financing

Vaidya Sane Ayurved Laboratories operating cash flow ₹11 Cr, investing ₹-10 Cr, financing ₹-1 Cr, net cash flow ₹0 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023
Operating Activities 11 -1 0
Investing Activities -10 -13 1
Financing Activities -1 15 -1
Net Cash Flow 0 1 -1